Clinical Trials Browser

Phase 1 × Leukemia, Prolymphocytic, T-Cell × itacitinib × Clear all

Leukemia, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myelomonocytic, Chronic

NCT03989466 2024-10-10

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia

Phase 1 Completed

15 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Prolymphocytic, T-Cell

Clinical Trials

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia